Fiduciary Trust’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Fiduciary Trust's KRYS Position: Q3 2026 in Review
Fiduciary Trust reduced its Krystal Biotech (KRYS) stake by 5.8% in Q3 2026, selling an estimated $17K and leaving 791 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #765.
Fiduciary Trust first reported a position in KRYS in Q4 2025 and has held it in 4 quarters since. The position peaked at $312K in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Fiduciary Trust held 791 shares of Krystal Biotech worth $263K as of Q3 2026.
- Fiduciary Trust sold 49 Krystal Biotech shares in Q3 2026, an estimated $17K.
- Krystal Biotech made up ﹤0.01% of Fiduciary Trust's portfolio in Q3 2026, its #765 holding.
- Fiduciary Trust first reported a position in Krystal Biotech in Q4 2025 and has held it in 4 quarters since.
- Fiduciary Trust's Krystal Biotech position peaked at $312K in Q2 2026.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Fiduciary Trust's 13F filing for Q3 2026, filed 16 Nov 2026.